October 27, 2020Open Access
Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19
Key Points
Key points are not available for this paper at this time.
Abstract
The King's and MiToS staging systems provided utility in assessing clinical progression in Edaravone Study 19. These findings may support the use of staging systems as end points in ALS clinical trials and to understand the timing of benefit as measured by these scales.